These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9056674)

  • 21. Nuclear topography and expression of the BCR/ABL fusion gene and its protein level influenced by cell differentiation and RNA interference.
    Bártová E; Harnicarová A; Pacherník J; Kozubek S
    Leuk Res; 2005 Aug; 29(8):901-13. PubMed ID: 15978941
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alterations in membrane lipid dynamics of leukemic cells undergoing growth arrest and differentiation: dependency on the inducing agent.
    Nathan I; Ben-Valid I; Henzel R; Masalha H; Baram SN; Dvilansky A; Parola AH
    Exp Cell Res; 1998 Mar; 239(2):442-6. PubMed ID: 9521862
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased glutathione S-transferase P1-1 expression by mRNA stabilization in hemin-induced differentiation of K562 cells.
    Schnekenburger M; Morceau F; Duvoix A; Delhalle S; Trentesaux C; Dicato M; Diederich M
    Biochem Pharmacol; 2004 Sep; 68(6):1269-77. PubMed ID: 15313425
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interferon induces up-regulation of Spi-1/PU.1 in human leukemia K562 cells.
    Gutiérrez P; Delgado MD; Richard C; Moreau-Gachelin F; León J
    Biochem Biophys Res Commun; 1997 Nov; 240(3):862-8. PubMed ID: 9398659
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Wilms' tumor gene, WT1, mRNA is down-regulated during induction of erythroid and megakaryocytic differentiation of K562 cells.
    Phelan SA; Lindberg C; Call KM
    Cell Growth Differ; 1994 Jun; 5(6):677-86. PubMed ID: 8086342
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Decursin and PDBu: two PKC activators distinctively acting in the megakaryocytic differentiation of K562 human erythroleukemia cells.
    Kim HH; Ahn KS; Han H; Choung SY; Choi SY; Kim IH
    Leuk Res; 2005 Dec; 29(12):1407-13. PubMed ID: 15992925
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential expression of ras protooncogenes during in vitro differentiation of human erythroleukemia cells.
    Delgado MD; Quincoces AF; Gómez-Casares MT; Martínez CA; Cuadrado MA; Richard C; León J
    Cancer Res; 1992 Nov; 52(21):5979-84. PubMed ID: 1394224
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discrimination of target by siRNA: designing of AML1-MTG8 fusion mRNA-specific siRNA sequences.
    Kasashima K; Sakota E; Kozu T
    Biochimie; 2004; 86(9-10):713-21. PubMed ID: 15556282
    [TBL] [Abstract][Full Text] [Related]  

  • 29. K562 erythroleukemia cells express cytokeratins 8, 18, and 19 and epithelial membrane antigen that disappear after induced differentiation.
    Järvinen M; Andersson LC; Virtanen I
    J Cell Physiol; 1990 May; 143(2):310-20. PubMed ID: 1692028
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A hematopoietic-specific transmembrane protein, Art-1, is possibly regulated by AML1.
    Harada Y; Harada H; Downing JR; Kimura A
    Biochem Biophys Res Commun; 2001 Jun; 284(3):714-22. PubMed ID: 11396961
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of 1-beta-D-arabinofuranosylcytosine and phorbol ester on differentiation of human K562 erythroleukemia cells.
    Watanabe T; Mitchell T; Sariban E; Sabbath K; Griffin J; Kufe D
    Mol Pharmacol; 1985 Jun; 27(6):683-8. PubMed ID: 3858662
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Accumulation of gamma-globin mRNA and induction of irreversible erythroid differentiation after treatment of CML cell line K562 with new doxorubicin derivatives.
    Szulawska A; Arkusinska J; Czyz M
    Biochem Pharmacol; 2007 Jan; 73(2):175-84. PubMed ID: 17097070
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spi-1/PU.1 proto-oncogene induces opposite effects on monocytic and erythroid differentiation of K562 cells.
    Delgado MD; Gutiérrez P; Richard C; Cuadrado MA; Moreau-Gachelin F; León J
    Biochem Biophys Res Commun; 1998 Nov; 252(2):383-91. PubMed ID: 9826539
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bcl-x is a regulatory factor of apoptosis and differentiation in megakaryocytic lineage cells.
    Terui Y; Furukawa Y; Kikuchi J; Iwase S; Hatake K; Miura Y
    Exp Hematol; 1998 Mar; 26(3):236-44. PubMed ID: 9502620
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of an alternatively spliced form of the mouse AML1/RUNX1 gene transcript AML1c and its expression in early hematopoietic development.
    Fujita Y; Nishimura M; Taniwaki M; Abe T; Okuda T
    Biochem Biophys Res Commun; 2001 Mar; 281(5):1248-55. PubMed ID: 11243869
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Leukemia-associated ETO homologues are differently expressed during hematopoietic differentiation.
    Lindberg SR; Olsson A; Persson AM; Olsson I
    Exp Hematol; 2005 Feb; 33(2):189-98. PubMed ID: 15676213
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Basic fibroblast growth factor modulates the expression of glycophorin A and c-kit and inhibits erythroid differentiation in K562 cells.
    Burger PE; Lukey PT; Coetzee S; Wilson EL
    J Cell Physiol; 2002 Jan; 190(1):83-91. PubMed ID: 11807814
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phorbol ester induction of differentiation and apoptosis in the K562 cell line is accompanied by marked decreases in the stability of globin mRNAs and decreases in the steady state level of mRNAs encoding for ribosomal proteins L35, L31, L27, and L21.
    Lin CH; Palma JF; Solomon WB
    Cell Mol Biol Res; 1994; 40(1):13-26. PubMed ID: 7804323
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of activin A/erythroid differentiation factor on erythroid and megakaryocytic differentiations of mouse erythroleukemia (Friend) cells: evidence for two distinct modes of cell response.
    Okafuji K; Kaku K; Seguchi M; Tanaka H; Azuno Y; Kaneko T
    Exp Hematol; 1995 Mar; 23(3):210-6. PubMed ID: 7875239
    [TBL] [Abstract][Full Text] [Related]  

  • 40. c-sis/platelet-derived growth factor-B promoter requirements for induction during the 12-O-tetradecanoylphorbol-13-acetate-mediated megakaryoblastic differentiation of K562 human erythroleukemia cells.
    Kujoth GC; Fahl WE
    Cell Growth Differ; 1997 Sep; 8(9):963-77. PubMed ID: 9300179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.